Seeing Is Believing
ARMP is currently covered by 1 analysts with an average price target of $5.6. This is a potential upside of $2.84 (102.9%) from yesterday's end of day stock price of $2.76.
Armata Pharmaceuticals's activity chart (see below) currently has 6 price targets and 6 ratings on display. The stock rating distribution of ARMP is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 258 days.
Highest price target for ARMP is $7, Lowest price target is $7, average price target is $5.6.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 14-Aug-2023. First documented stock forecast 31-Oct-2019.
Currently out of the existing stock ratings of ARMP, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
7
$4.14 (144.76%)
7
8 months 24 days ago
1/6 (16.67%)
$2.84 (68.27%)
258
What is ARMP (Armata Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ARMP (Armata Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ARMP (Armata Pharmaceuticals)?
Which analyst is the currently most bullish on ARMP (Armata Pharmaceuticals)?